− NorthStar, leading the way as the sole U.S. commercial supplier of molybdenum-99 (Mo-99), continues expansion efforts for increased capacity and ongoing reliable supply for diagnostic imaging − ...

NorthStar Medical Radioisotopes, a privately-held Wisconsin company, announced today that the FDA and the Nuclear Regulatory Commission (NRC) approved the company’s RadioGenix System for producing ...

Tackling supply shortages: As the supply chain for medical radioisotopes continues to struggle, researchers are developing new methods for producing technetium-99m, and exploring the potential of ...

A commonly used radioisotope, technetium-99m, used in medical diagnoses regularly suffers from shortages due to being produced at aging nuclear reactors that often shut down for repairs. But an ...

The Food and Drug Administration recently announced approval of the RadioGenix™ System, a technetium 99m (Tc-99m) generator. The RadioGenix™ System is developed by NorthStar Medical Radioisotopes, LLC ...

Best 6–15 MeV Compact Variable Energy Cyclotron System (Open View) Krishnan Suthanthiran, President & Founder of TeamBest Companies & Best Cure Foundation Everyone deserves the Best healthcare.” — ...

The Australian Nuclear Science and Technology Organisation expects to be able to recommence production of technetium-99m generators this week, following repair to a conveyer belt. ANSTO's new ...

Beloit, Wisconsin-based NorthStar Medical Technologies, a provider of radioisotopes used for medical imaging and therapy, has raised $100 million in funding. The investor was Oberland Capital. BELOIT, ...

A mechanical failure that caused the suspension of Australian manufacture of technetium-99m (Tc-99m) generators has been addressed, but resumption of production is still some weeks away. Australia's ...

Molybdenum-99 remains a cornerstone of modern nuclear medicine as the parent radionuclide for technetium-99m, the workhorse in diagnostic imaging. Traditionally produced through the fission of uranium ...